The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies

Blood

Volumn 119, Issue 10, 2012, Pages 2392-2400

  Dennis, Jessica ^a   Johnson, Candice Y ^b   Adediran, Adeniyi Samuel ^a   De Andrade, Mariza ^c   Heit, John A ^c   Morange, Pierre Emmanuel ^d,e   Trégouët, David Alexandre ^f,g,h   Gagnon, France ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b EMORY UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d CNRS   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f INSERM   (France)

^g L'Institut Hospitalo universitaire de Cardiologie metabolisme et Nutrition   (France)

^h SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR; GLYCINE; PROTEIN C; PROTEIN VARIANT; SERINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; CONFIDENCE INTERVAL; DIABETES MELLITUS; EMBASE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDLINE; META ANALYSIS; OBESITY; OBSERVATIONAL STUDY; POINT MUTATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM;

EID: 84863419775     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-383448     Document Type: Article

References (53)

1. Geiger M. Soluble protein C receptor: why? Blood. 2008;111(7):3301-3302.
2. Gandrille S. Endothelial cell protein C receptor and the risk of venous thrombosis. Haematologica. 2008;93(6):812-816. (Pubitemid 351821717)
3. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A. 1996;93(19):10212- 10216. (Pubitemid 26314601)
4. Laszik Z, Mitro A, Taylor FB, Jr Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation. 1997;96(10):3633-3640. (Pubitemid 27513443)
5. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109(8): 3161-3172. (Pubitemid 46572500)
6. Ireland HA, Cooper JA, Drenos F, et al. FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men. Arterioscler Thromb Vasc Biol. 2009;29(11):1968-1974.
7. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Mohan Rao LV. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem. 2007;282(16):11849- 11857.
8. Liaw PC, Neuenschwander PF, Smirnov MD, Esmon CT. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem. 2000;275(8):5447-5452. (Pubitemid 30115177)
9. Navarro S, Medina P, Mira Y, et al. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica. 2008; 93(6):885-891. (Pubitemid 351821725)
10. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, De Visser MCH, Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost. 2004;2(8):1305-1310.
11. Simioni P, Morboeuf O, Tognin G, et al. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. Thromb Res. 2006;117(5):523-528. (Pubitemid 43326137)
12. Simmonds RE, Lane DA. Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: Comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains. Blood. 1999;94(2):632-641. (Pubitemid 29323877)
13. Gu JM, Crawley JT, Ferrell G, et al. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem. 2002;277(45): 43335-43343. (Pubitemid 35285721)
14. Biguzzi E, Merati G, Liaw PCY, et al. A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost. 2001;86(4):945-948. (Pubitemid 32979129)
15. Biguzzi E, Gu J-, Merati G, Esmon NL, Esmon CT. Point mutations in the endothelial protein C receptor (EPCR) promoter. Thromb Haemost. 2002;87(6):1085-1086. (Pubitemid 34624900)
16. Medina P, Navarro S, Estelles A, Espana F. Polymorphisms in the endothelial protein C receptor gene and thrombophilia. Thromb Haemost. 2007; 98(3):564-569. (Pubitemid 47412882)
17. Medina P, Navarro S, Estelles A, et al. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thromb Haemost. 2004; 91(5):905-911. (Pubitemid 38647493)
18. Ireland H, Konstantoulas CJ, Cooper JA, et al. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis. 2005;183(2):283-292. (Pubitemid 41579279)
19. Reiner AP, Carty CL, Jenny NS, et al. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: The Cardiovascular Health Study. J Thromb Haemost. 2008;6(10):1625-1632.
20. Qu D, Wang Y, Song Y, Esmon NL, Esmon CT. The Ser219->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost. 2006;4(1): 229-235.
21. Saposnik B, Lesteven E, Lokajczyk A, Esmon CT, Aiach M, Gandrille S. Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma. Blood. 2008;111(7):3442-3451.
22. National Center for Biotechnology Information. dbSNP Short Genetic Variations Cluster Report: rs867186. Available from: http://www.ncbi.nlm. nih.gov/projects/SNP/snp-ref.cgi?searchType=adhoc-search&type=rs&rs= rs867186. Accessed May 28, 2011.
23. Rajeevan H, Cheung KH, Gadagkar R, et al. ALFRED: an allele frequency database for microevolutionary studies. Evol Bioinform Online. 2005;1:1-10.
24. Smith NL, Chen MH, Dehghan A, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382-1392.
25. Reitsma PH, Rosendaal FR. Past and future of genetic research in thrombosis. J Thromb Haemost. 2007;5(suppl 1):264-269. (Pubitemid 46958841)
26. Lowe GD. Common risk factors for both arterial and venous thrombosis. Br J Haematol. 2008; 140(5):488-495. (Pubitemid 351230085)
27. Prandoni P. Venous thromboembolism and atherosclerosis: is there a link? J Thromb Haemost. 2007;5(suppl 1):270-275. (Pubitemid 46958842)
28. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367(9511):651-658. (Pubitemid 43289155)
29. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948-957. (Pubitemid 37500767)
30. Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009; 113(21):5298-5303.
31. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333-338.
32. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1):93-102. (Pubitemid 350301144)
33. Undas A, Szułdrzyński K, Brummel-Ziedins KE, Tracz W, Zmudka K, Mann KG. Systemic blood coagulation activation in acute coronary syndromes. Blood. 2009;113(9):2070-2078.
34. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7(10):781-791. (Pubitemid 44413222)
35. Saposnik B, Reny J-, Gaussem P, Emmerich J, Aiach M, Gandrille S. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood. 2004;103(4):1311-1318. (Pubitemid 38168642)
36. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, eds. Introduction to Meta-Analysis. Chichester, United Kingdom: John Wiley & Sons Ltd; 2009.
37. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. (Pubitemid 27387172)
38. Ziegler A, Van Steen K, Wellek S. Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Treat. 2011;128(1):197-201.
39. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1): 120-132. (Pubitemid 351228620)
40. Little J, Higgins JPT. The HuGENet HuGE Review Handbook. Version 1.0. Available from: http://www.hugenet.org.uk/resources/handbook. php. Accessed February 28, 2006.
41. Medina P, Navarro S, Estelles A, Vaya A, Bertina RM, Espana F. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factors V Leiden. Thromb Haemost. 2005;94(2):389-394. (Pubitemid 41122494)
42. Butterworth AS, Braund PS, Farrall M, et al; IBC 50K CAD Consortium. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011;7(9):e1002260.
43. Galanaud JP, Cochery-Nouvellon E, Alonso S, et al. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy. J Thromb Haemost. 2010;8(4):707-713.
44. Bezemer ID, Bare LA, Doggen CJ, et al. Gene variants associated with deep vein thrombosis. JAMA. 2008;299(11):1306-14. (Pubitemid 351439076)
45. Yamagishi K, Cushman M, Heckbert SR, Tsai MY, Folsom AR. Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol. 2009;145(2):221-226.
46. Pecheniuk NM, Elias DJ, Xu X, Griffin JH. Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry. Thromb Haemost. 2008;99(2):453-455. (Pubitemid 351230981)
47. Chen XD, Tian L, Li M, JinW, Zhang HK, Zheng CF. Relationship between endothelial cell protein c receptor gene 6936a/g polymorphisms and deep venous thrombosis. Chin Med J (Engl). 2011;124(1):72-75.
48. Medina P, Navarro S, Corral J, et al. Endothelial protein C receptor polymorphisms and risk of myocardial infarction. Haematologica. 2008; 93(9):1358-1363.
49. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Featured Data & Statistics: Prevalence of Heart Disease-United States (2005). Available from: http://www.cdc.gov/ DataStatistics/archive/heartdisease.html. Accessed April 18, 2011.
50. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19(1):149-150. (Pubitemid 36150192)
51. Tang W, Basu S, Kong X, et al. Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. Blood. 2010; 116(23):5032-5036.
52. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005;2005:1- 12.
53. Guella I, Duga S, Ardissino D, et al. Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the Italian population. Thromb Haemost. 2011; 106(4):655-664.